scholarly article | Q13442814 |
P50 | author | Harry Pantazopoulos | Q80206971 |
P2093 | author name string | Ross J Baldessarini | |
Nicholas Lange | |||
Sabina Berretta | |||
P2860 | cites work | Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder | Q48892807 |
Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain | Q49019867 | ||
Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. | Q50995292 | ||
Memory and verbal learning functions in twins with bipolar-I disorder, and the role of information-processing speed. | Q51930982 | ||
Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. | Q52167923 | ||
Differences in Ca2+ buffering properties between excitatory and inhibitory hippocampal neurons from the rat | Q58191262 | ||
Diminished Suppression of the P50 Auditory Evoked Potential in Bipolar Disorder Subjects With a History of Psychosis | Q59795838 | ||
Increased density of entorhinal glutamate-immunoreactive vertical fibers in schizophrenia | Q60054580 | ||
Reduced GABA uptake sites in the temporal lobe in schizophrenia | Q60054596 | ||
Postnatal development of the α1 containing GABAA receptor subunit in rat hippocampus | Q60462291 | ||
A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia | Q61713924 | ||
Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia | Q62612478 | ||
Manic-depressive and pure manic states after brain lesions | Q68197694 | ||
A review of MRI findings in schizophrenia | Q24657354 | ||
Anomalous asymmetry of fusiform and parahippocampal gyrus gray matter in schizophrenia: A postmortem study | Q28141734 | ||
Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins | Q28189235 | ||
The medial temporal lobe | Q29615990 | ||
Prefrontal cortical-amygdalar metabolism in major depression | Q30579598 | ||
Frontotemporal neural systems in bipolar disorder | Q30739425 | ||
Pathogenesis of schizophrenia: Part I. Symptomatology, cognitive characteristics and brain morphology | Q30760640 | ||
The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings | Q33206291 | ||
GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder | Q33948632 | ||
Anatomical organization of the parahippocampal-hippocampal network | Q33981189 | ||
Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia | Q33981274 | ||
Hippocampal-neocortical interaction: a hierarchy of associativity | Q34031594 | ||
New neurochemical markers for psychosis: a working hypothesis of their operation | Q34074201 | ||
Two-dimensional versus three-dimensional cell counting: a practical perspective | Q34133239 | ||
'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice | Q34216909 | ||
Diagnostic Criteria for Use in Psychiatric Research | Q34226390 | ||
A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey: I. Convergence in the entorhinal, prorhinal, and perirhinal cortices | Q69029008 | ||
Prenatal developmental disturbances in the limbic allocortex in schizophrenics | Q69518888 | ||
Manic-like state after bilateral orbitofrontal and right temporoparietal injury: efficacy of clonidine | Q69618072 | ||
[Neuropathology of schizophrenias] | Q70735291 | ||
Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects | Q71479819 | ||
Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain | Q71569685 | ||
The human entorhinal cortex: a cytoarchitectonic analysis | Q71700880 | ||
Delayed cell death in the contralateral hippocampus following kainate injection into the CA3 subfield | Q72000562 | ||
Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenetic and clinical aspects | Q72201148 | ||
Parvalbumin-immunoreactive neurons in the entorhinal cortex of the rat: localization, morphology, connectivity and ultrastructure | Q72224756 | ||
Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder | Q73250666 | ||
Input and output stations of the entorhinal cortex: superficial vs. deep layers or lateral vs. medial divisions? | Q73489988 | ||
Quantification without pontification: choosing a method for counting objects in sectioned tissues | Q73712076 | ||
Expression of calbindin-D28k and parvalbumin during development of rat's basolateral amygdaloid complex | Q73964600 | ||
Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus | Q74453176 | ||
Voxel-based morphometry in adolescents with bipolar disorder: first results | Q80321652 | ||
GABAA receptor gamma subunits in the prefrontal cortex of patients with schizophrenia and bipolar disorder | Q80347395 | ||
Estimation of nuclear population from microtome sections | Q82126847 | ||
Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder | Q34282011 | ||
Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder | Q34331509 | ||
Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines | Q34355797 | ||
Hippocampus as comparator: role of the two input and two output systems of the hippocampus in selection and registration of information | Q34456344 | ||
Cell pathology in bipolar disorder | Q34692741 | ||
Neuronal calcium-binding proteins and schizophrenia. | Q34775710 | ||
Studies of individuals with schizophrenia never treated with antipsychotic medications: a review | Q34985042 | ||
Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms | Q35187199 | ||
Neurobiology of emotion perception II: Implications for major psychiatric disorders | Q35208704 | ||
Postnatal development of calcium-binding proteins immunoreactivity (parvalbumin, calbindin, calretinin) in the human entorhinal cortex. | Q35631857 | ||
Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal models | Q35796571 | ||
The rhinal cortices: a wall of inhibition between the neocortex and the hippocampus | Q35935182 | ||
A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia | Q36070114 | ||
Coexistence of parvalbumin and GABA in nonpyramidal neurons of the rat entorhinal cortex | Q36809073 | ||
Role of the calcium-binding protein parvalbumin in short-term synaptic plasticity. | Q37295348 | ||
Hippocampal and brain stem activation during word retrieval after repeated and semantic encoding | Q38432974 | ||
GABAergic neuronal subtypes in the human frontal cortex--development and deficits in schizophrenia | Q38523551 | ||
Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression. | Q40454288 | ||
Methods for determining numbers of cells and synapses: a case for more uniform standards of review | Q40958739 | ||
Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia | Q41199819 | ||
Limbic pathology in schizophrenia: the entorhinal region--a morphometric study. | Q41395921 | ||
Information-processing abnormalities: trait- and state-dependent components | Q41474814 | ||
The medial temporal lobe in schizophrenia | Q41581012 | ||
Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics | Q41581740 | ||
Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia | Q41652023 | ||
The entorhinal cortex of the monkey: II. Cortical afferents | Q42116756 | ||
Calcium buffering properties of calbindin D28k and parvalbumin in rat sensory neurones | Q42499459 | ||
Distribution of parvalbumin-immunoreactive cells and fibers in the human amygdaloid complex | Q42512656 | ||
The entorhinal cortex of the monkey: III. Subcortical afferents | Q42524296 | ||
Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder | Q43593933 | ||
Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia | Q43601374 | ||
The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects | Q43744085 | ||
Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain | Q43870684 | ||
Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex | Q44045573 | ||
Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons | Q44059494 | ||
Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex | Q44167711 | ||
Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins | Q44174112 | ||
Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus | Q44355455 | ||
Parvalbumin and calbindin D-28K in the human entorhinal cortex. An immunohistochemical study | Q44402652 | ||
Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groups | Q44466287 | ||
Contributions from brain imaging to the elucidation of pathophysiology of bipolar disorder | Q44532052 | ||
Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium | Q44715726 | ||
Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits | Q44926893 | ||
Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder | Q45003272 | ||
Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics. | Q45081917 | ||
Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains | Q45251046 | ||
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. | Q46022290 | ||
Selective neuron loss in the paraventricular nucleus of hypothalamus in patients suffering from major depression and bipolar disorder | Q46416538 | ||
Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder | Q46546217 | ||
Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions | Q47354472 | ||
Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain | Q47856910 | ||
Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. | Q47914893 | ||
Molecular evidence for mitochondrial dysfunction in bipolar disorder | Q48017201 | ||
Regio entorhinalis in schizophrenia: more evidence for migrational disturbances and suggestions for a new biological hypothesis | Q48115373 | ||
Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia | Q48122394 | ||
Topographic organization of the reciprocal connections between the monkey entorhinal cortex and the perirhinal and parahippocampal cortices. | Q48163406 | ||
Impaired recruitment of the hippocampus during conscious recollection in schizophrenia | Q48242681 | ||
Basket-like interneurones in layer II of the entorhinal cortex exhibit a powerful NMDA-mediated synaptic excitation | Q48347916 | ||
Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder | Q48377734 | ||
Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity | Q48426648 | ||
A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives | Q48438450 | ||
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders | Q48459917 | ||
Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage | Q48465361 | ||
Intrinsic projections of the retrohippocampal region in the rat brain. I. The subicular complex | Q48478733 | ||
Perirhinal and postrhinal cortices of the rat: interconnectivity and connections with the entorhinal cortex | Q48517432 | ||
Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics | Q48521493 | ||
A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia | Q48572580 | ||
A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia | Q48581063 | ||
Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease | Q48590034 | ||
Distribution of parvalbumin-, calretinin-, and calbindin-D28k-immunoreactive neurons and fibers in the human entorhinal cortex | Q48596760 | ||
Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy | Q48614993 | ||
Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients | Q48633690 | ||
Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study | Q48669559 | ||
Cytoarchitecture of the entorhinal cortex in schizophrenia | Q48675741 | ||
Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia | Q48691523 | ||
Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain | Q48724803 | ||
Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics | Q48729184 | ||
Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia | Q48764868 | ||
Short-term changes of parvalbumin and calbindin immunoreactivity in the rat hippocampus following cerebral ischemia | Q48836277 | ||
Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects | Q48855793 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
entorhinal cortex | Q2603645 | ||
bipolar disorder | Q131755 | ||
P304 | page(s) | 640-652 | |
P577 | publication date | 2006-09-01 | |
P1433 | published in | Biological Psychiatry | Q4914961 |
P1476 | title | Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia | |
P478 | volume | 61 |
Q34391520 | Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region |
Q37143399 | Bipolar disorder: from genes to behavior pathways |
Q38636760 | Calretinin and parvalbumin in schizophrenia and affective disorders: a mini-review, a perspective on the evolutionary role of calretinin in schizophrenia, and a preliminary post-mortem study of calretinin in the septal nuclei. |
Q28251880 | Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder |
Q34828363 | Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders |
Q50784007 | Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders. |
Q37035662 | Early intervention in bipolar disorder, part I: clinical and imaging findings |
Q35603175 | Extracellular matrix abnormalities in schizophrenia |
Q34398564 | Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia |
Q37433211 | Functional neuroanatomy of bipolar disorder: structure, function, and connectivity in an amygdala-anterior paralimbic neural system |
Q36073289 | GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders |
Q30503608 | Hippocampal interneurons are abnormal in schizophrenia |
Q35400508 | Hippocampal interneurons in bipolar disorder |
Q36960113 | Immature dentate gyrus: an endophenotype of neuropsychiatric disorders. |
Q37147332 | Is brain banking of psychiatric cases valuable for neurobiological research? |
Q30446669 | Modeling psychiatric disorders at the cellular and network levels |
Q90141029 | Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies |
Q41646482 | Reduced GABA neuron density in auditory cerebral cortex of subjects with major depressive disorder. |
Q34574517 | Reduced somatostatin in subgenual anterior cingulate cortex in major depression |
Q30375488 | Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia. |
Q35894870 | Size and shape of the caudate nucleus in individuals with bipolar affective disorder |
Q34279949 | Stereological Approaches to Identifying Neuropathology in Psychosis |
Q38256971 | Sugar glues for broken neurons |
Q33516071 | T2 relaxation time abnormalities in bipolar disorder and schizophrenia |
Q91049124 | The neuropathology of bipolar disorder: systematic review and meta-analysis |
Q52367971 | The tetrapartite synapse: a key concept in the pathophysiology of schizophrenia. |
Q47659457 | The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress |
Q57610553 | Transcriptomic Evidence for Alterations in Astrocytes and Parvalbumin Interneurons in Subjects With Bipolar Disorder and Schizophrenia |
Q34167002 | Water and metabolite transverse T2 relaxation time abnormalities in the white matter in schizophrenia |
Q87927295 | What can we learn about brain donors? Use of clinical information in human postmortem brain research |
Search more.